| Literature DB >> 28591834 |
Nan-Nan Lu1, Chao Tan1, Ning-He Sun1, Ling-Xiao Shao1, Xiu-Xiu Liu1,2, Yin-Ping Gao1,2, Rong-Rong Tao1, Quan Jiang1, Cheng-Kun Wang1, Ji-Yun Huang1, Kui Zhao3, Guang-Fa Wang3, Zhi-Rong Liu4, Kohji Fukunaga5, Ying-Mei Lu2,6, Feng Han1.
Abstract
Grb2-associated-binding protein 1 (Gab1) is a docking/scaffolding molecule known to play an important role in cell growth and survival. Here, we report that Gab1 is decreased in cholinergic neurons in Alzheimer's disease (AD) patients and in a mouse model of AD. In mice, selective ablation of Gab1 in cholinergic neurons in the medial septum impaired learning and memory and hippocampal long-term potentiation. Gab1 ablation also inhibited SK channels, leading to an increase in firing in septal cholinergic neurons. Gab1 overexpression, on the other hand, improved cognitive function and restored hippocampal CaMKII autorphosphorylation in AD mice. These results suggest that Gab1 plays an important role in the pathophysiology of AD and may represent a novel therapeutic target for diseases involving cholinergic dysfunction.Entities:
Mesh:
Substances:
Year: 2018 PMID: 28591834 PMCID: PMC7189983 DOI: 10.1093/cercor/bhx141
Source DB: PubMed Journal: Cereb Cortex ISSN: 1047-3211 Impact factor: 5.357